Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21975683 | 0.98 | ESR1 (0.32) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL18118809 | 0.96 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL21975682 | 0.95 | ESR1 (0.30) | ESR1ESR2 | |
| SCHEMBL18118688 | 0.95 | ESR1 (0.32) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL21975677 | 0.94 | ESR1 (0.32) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL17804644 | 0.94 | KDM4E (0.30) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL21975162 | 0.93 | — | — | |
| SCHEMBL16996028 | 0.92 | — | — | |
| SCHEMBL21975245 | 0.92 | ESR1 (0.32) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL17804713 | 0.92 | PIM3 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200144511-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DOOSAN CORPORATION (KR) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200144511-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, ORAI2, ORC3 | ESR1 145/4885ESR2 715/4885KDM4E 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.